Kidney Disease and Anemia in Elderly Patients

被引：10

作者：

Musio, Franco ^{[1
,2
]}

机构：

[1] Inova Fairfax Hosp, Dept Med, Nephrol Sect, Annandale, VA USA

[2] Nephrol Associates Northern Virginia, 13135 Lee Jackson Mem Highway,Suite 135, Fairfax, VA 22033 USA

来源：

CLINICS IN GERIATRIC MEDICINE | 2019年 / 35卷 / 03期

关键词：

Anemia; Elderly; Chronic kidney disease; Erythroid stimulating agents; STAGE RENAL-DISEASE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; GLOMERULAR-FILTRATION-RATE; SERUM CREATININE LEVELS; LEFT-VENTRICULAR MASS; DARBEPOETIN-ALPHA; EPOETIN-ALPHA; OLDER; HEMOGLOBIN; CLEARANCE;

D O I：

10.1016/j.cger.2019.03.009

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

Anemia is a very common complicating feature of chronic kidney disease (CKD) in the elderly. Noninvasive assessment of renal function in the elderly may include several equations although they may actually underestimate the true glomerular filtration rate (GFR). In summary, anemia in the setting of CKD in the elderly is generally underrecognized and under-treated, leading to associations of increased morbidity and mortality. The likelihood of benefits of treatment of anemia in this rapidly increasing subset of patients with CKD remains very high.

引用

页码：327 / +

页数：12

共 61 条

[1]

[Anonymous], 2012, Kidney Int Suppl, V2, P279, DOI [10.1038/kisup.2012.37, DOI 10.1038/KISUP.2012.37]

[2] Mechanisms of unexplained anemia in the nursing home [J].